Modern Diagnostic & Research Centre (BOM:544673) EBIT: ₹26.6 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544673 Modern Diagnostic & Research Centre Ltd BOM:544673
15 GF Score
Price ₹51.00
! 7 Warning Signs
View Full Analysis

What is Modern Diagnostic & Research Centre EBIT?

Modern Diagnostic & Research Centre BOM:544673 15 EBIT is ₹26.6 Mil as of Mar. 2026. GuruFocus rates BOM:544673 with a GF Score™ of 15/100. The stock has 7 warning signs investors should review.

Modern Diagnostic & Research Centre's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was ₹26.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹26.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Modern Diagnostic & Research Centre's annualized ROC % for the quarter that ended in Mar. 2026 was 5.39%. Modern Diagnostic & Research Centre's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 10.60%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Modern Diagnostic & Research Centre's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.54%.

Modern Diagnostic & Research Centre  (BOM:544673) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Modern Diagnostic & Research Centre's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=44.982 * ( 1 - 0% )/( (599.075 + 1070.592)/ 2 )
=44.982/834.8335
=5.39 %

where

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=645.743 - 127.509 - ( 7.842 - max(0, 319.172 - 238.331+7.842))
=599.075

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1185.982 - 116.304 - ( 94 - max(0, 434.413 - 433.499+94))
=1070.592

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Modern Diagnostic & Research Centre's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=53.23/( ( (386.247 + max(19.554, 0)) + (567.019 + max(31.595, 0)) )/ 2 )
=53.23/( ( 405.801 + 598.614 )/ 2 )
=53.23/502.2075
=10.60 %

where Working Capital is:

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(127.569 + 49.168 + 24.055) - (127.509 + 0 + 53.729)
=19.554

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(157.819 + 70.841 + 5.067) - (116.304 + 0 + 85.828)
=31.595

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Modern Diagnostic & Research Centre's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=26.615/1047.024
=2.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Diagnostic & Research Centre EBIT Related Terms

Modern Diagnostic & Research Centre EBIT Historical Data

* Premium members only.

The historical data trend for Modern Diagnostic & Research Centre's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Diagnostic & Research Centre EBIT Chart

Modern Diagnostic & Research Centre Annual Data
Trend Mar23 Mar24 Mar25 Mar26
EBIT
-45.59 86.50 147.24 84.31

Modern Diagnostic & Research Centre Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
EBIT 0.00 0.00 0.00 26.62

BOM:544673 vs TMO, DHR, IDXX: EBIT Comparison

For the Diagnostics & Research subindustry, Modern Diagnostic & Research Centre's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Modern Diagnostic & Research Centre EV-to-EBIT vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Modern Diagnostic & Research Centre's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Modern Diagnostic & Research Centre's EV-to-EBIT falls into.


BOM:544673
15GF Score
Modern Diagnostic & Research Centre Ltd BOM:544673
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Modern Diagnostic & Research Centre EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹26.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹26.6 Mil mean?
Modern Diagnostic & Research Centre (BOM:544673) has a EBIT of ₹26.6 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Modern Diagnostic & Research Centre.
Is Modern Diagnostic & Research Centre's EBIT too high?
Modern Diagnostic & Research Centre's current EBIT is ₹26.6 Mil. Overall, Modern Diagnostic & Research Centre has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Modern Diagnostic & Research Centre's EBIT compare to TMO and DHR?
Modern Diagnostic & Research Centre's EBIT of ₹26.6 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Diagnostics & Research company?
A good EBIT depends on the Medical Diagnostics & Research industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Modern Diagnostic & Research Centre. Modern Diagnostic & Research Centre's current EBIT is ₹26.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Diagnostic & Research Centre stock overvalued right now?
Modern Diagnostic & Research Centre (BOM:544673) has a current EBIT of ₹26.6 Mil. The current EBIT is ₹26.6 Mil. Modern Diagnostic & Research Centre's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Modern Diagnostic & Research Centre (BOM:544673), the current EBIT is ₹26.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Modern Diagnostic & Research Centre Business Description

Address New Railway Road, 363/4 Jawahar Nagar, Sadar Bazar, Gurugram, HR, IND, 122001
Modern Diagnostic & Research Centre Ltd is a services provider in diagnostic and related healthcare tests services in India. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through Its integrated, nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. The company provides healthcare tests and services for use in core testing, patients' diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
15GF Score

Get the complete analysis for BOM:544673

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹51.00
Price